Expansion Therapeutics – Expansion Therapeutics

Press Release

Expansion Therapeutics Names Elliot Ehrich, M.D., Chief Medical Officer

Former EVP of R&D and Chief Medical Officer at Alkermes joins Expansion to advance portfolio…

Expansion TherapeuticsNovember 13, 2018

Matthew D. Disney, Ph.D., Scientific Founder of ExpansionRx, Named BioFlorida’s Entrepreneur of the Year

Event

Matthew Disney, Ph.D., Presents at the 2018 Myotonic Dystrophy Foundation Annual Conference

Expansion TherapeuticsOctober 4, 2018

Small Molecules Get the Message – Nature Biotechnology

Small Molecule Silences Cancer-driving RNA, Opens Up Previously Undruggable Targets – FierceBiotech

Novel RNA-Modifying Tool Corrects Genetic Diseases, Including Driver of Triple-negative Breast Cancer – TSRI

Expanding Small Molecule Horizons – BioCentury

Press Release

Expansion Therapeutics Raises $55.3 Million in Series A Financing to Advance Portfolio of Novel RNA Targeted Small Molecule Medicines to Treat Rare Diseases

Names Kevin M. Forrest, Ph.D. President and CEO Proprietary technology based on pioneering work from…

Expansion TherapeuticsJanuary 3, 2018

Small Molecules Against RNA Targets Attract Big Backers – Nature Reviews Drug Discovery

The RNA Drug Hunters – Chemical and Engineering News